Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > How many big pharmas and what are they buying

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jun 04, 2023 9:33am

305 Views

Post# 35479052

RE:RE:RE:RE:RE:RE:How many big pharmas and what are they buying

Actually StevenBirch a rough estimate of fair value can be calculated by the average number of new patients per year with say 2 to 3 treatments. Although just a theoretical calculation it would still be a working base for both Theralase and possible partner to negotiate the partnership. Beyond new patients are also people who are currently being treated and might migrate to Theralase's treatment after TLT completes their Phase1 study.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments